The response to IV rt-PA in very old stroke patients

被引:32
作者
Gomez-Choco, M. [1 ]
Obach, V. [1 ]
Urra, X. [1 ]
Amaro, S. [1 ]
Cervera, A. [1 ]
Vargas, M. [1 ]
Chamorro, A. [1 ]
机构
[1] Hosp Clin Barcelona, Inst Neurosci, Stroke Unit, Barcelona 08036, Spain
关键词
age; elderly; gender; sex; stroke therapy; thrombolysis;
D O I
10.1111/j.1468-1331.2007.02042.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The use of rtPA in stroke patients aged > 80 years remains controversial and it is debated whether there are sex-based differences in the response to rtPA. We assessed the clinical value of thrombolytic therapy in patients aged > 80 years (elderly group) in comparison with a non-elderly group, and evaluated the existence of sex differences in the response to rtPA. All consecutive patients (n = 157) treated with rtPA were prospectively assessed since July 2001, including 49 elderly patients who fulfilled the National Institute of Neurological Disorders and Stroke (NINDS) criteria. Changes of the National Institute of Health Stroke Scale (NIHSS) score at 1 h, 24 h, and 7 days after rtPA administration, favourable outcome at day 90 [(modified Rankin Scale) mRS 0-1, or 2 if mRS = 2 before the stroke], symptomatic bleedings, and death rates were compared between elderly and non-elderly patients. Using logistic regression, baseline NIHSS score [odds ratio (OR) 0.59, 95% confidence interval (CI) 0.41-0.84] was an independent predictor of favourable outcome, but not sex (OR 0.72, 95% CI 0.33-1.56), or age > 80 years (OR 0.74, 95% CI 0.32-1.70). The rates of clinical improvement, mortality, or symptomatic CNS bleeding were also unrelated to age and sex. In conclusion, the response to IV rtPA is not impaired in elderly stroke patients and male and female are equally responsive.
引用
收藏
页码:253 / 256
页数:4
相关论文
共 18 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 years) stroke patients [J].
Berrouschot, J ;
Röther, J ;
Glahn, J ;
Kucinski, T ;
Fiehler, J ;
Thomalla, G .
STROKE, 2005, 36 (11) :2421-2425
[3]   Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke [J].
Elkind, M. S. V. ;
Prabhakaran, S. ;
Pittman, J. ;
Koroshetz, W. ;
Jacoby, M. ;
Johnston, K. C. .
NEUROLOGY, 2007, 68 (11) :842-848
[4]   Thrombolysis in stroke patients aged 80 years and older:: Swiss survey of IV thrombolysis [J].
Engelter, ST ;
Reichhart, M ;
Sekoranja, L ;
Georgiadis, D ;
Baumann, A ;
Weder, B ;
Müller, F ;
Lüthy, R ;
Arnold, M ;
Michel, P ;
Mattle, HP ;
Tettenborn, B ;
Hungerbühler, HJ ;
Baumgartner, RW ;
Sztajzel, R ;
Bogousslavsky, J ;
Lyrer, PA .
NEUROLOGY, 2005, 65 (11) :1795-1798
[5]   Intravenous thrombolysis in stroke patients of ≥80 versus <80 years of age -: a systematic review across cohort studies [J].
Engelter, Stefan T. ;
Bonati, Leo H. ;
Lyrer, Philippe A. .
AGE AND AGEING, 2006, 35 (06) :572-580
[6]   ASSOCIATION BETWEEN INCREASED ESTROGEN STATUS AND INCREASED FIBRINOLYTIC POTENTIAL IN THE FRAMINGHAM OFFSPRING STUDY [J].
GEBARA, OCE ;
MITTLEMAN, MA ;
SUTHERLAND, P ;
LIPINSKA, I ;
MATHENEY, T ;
XU, P ;
WELTY, FK ;
WILSON, PWF ;
LEVY, D ;
MULLER, JE ;
TOFLER, GH .
CIRCULATION, 1995, 91 (07) :1952-1958
[7]  
Hacke W, 2004, LANCET, V363, P768
[8]  
Holliday R, 1999, LANCET, V354, P4
[9]   Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke - A pooled analysis of randomized clinical trials [J].
Kent, DM ;
Price, LL ;
Ringleb, P ;
Hill, MD ;
Selker, HP .
STROKE, 2005, 36 (01) :62-65
[10]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587